(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INTELLISEQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INTELLISEQ

ST13

US500000087597320

Class

44

Filing

87597320

Registration

6389557

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

06/16/2026

Trademark type

Combined

Nice classes

44

Filing date

09/06/2017

Registration date

06/15/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/15/2021

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/17/2021

First use in commerce

02/17/2021

Drawing code

3

Owner type

16

Owner location

Krakow, Malopolska, PL

Examiner

FIRST, VIVIAN M

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of thick circle, broken on the bottom right position, surrounding DNA helix (consisting of two symmetric pentagons with rectangle in the center of each one), localized vertically in the center of the circle (the circle touches both ends of the DNA helix), with a word "intelliseq" on the right site of the figure.

Holders and representatives

Holders

INTELLISEQ

Representatives

Ranjini Acharya Pillsbury Winthrop Shaw Pittman LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Genetic testing for medical purposes; prenatal testing for genetic disorders; isolatingtestinganalyzingevaluating nucleic acids for medical purposes; genomics and bioinformatics testinggenetic testing for medical diagnostic and treatment purposes; DNA or RNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of genomics and biological sequence processing and analysis for medical diagnosis and treatment purposes; providing medical information for the purposes of medical diagnosis and treatment in the field of molecular genetics; identification and testing of DNA samples for health care purposes; health care servicesgenomics and data science to provide optimal health and disease prevention to patients; providing an online resource center featuring personalized health information based on genetic information and diagnostics; bioinformatics analysis for medical diagnostic and personalized treatment purposes; nucleic acid analysis and screening for medical diagnostic and treatment purposes

Publications

History of USPTO decisions and trademark events.

42 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/15/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/15/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/11/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/10/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/24/2021

IUAF

USE AMENDMENT FILED

03/10/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/10/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/10/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/10/2021

EISU

TEAS STATEMENT OF USE RECEIVED

03/09/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/24/2020

EX5G

SOU EXTENSION 5 GRANTED

09/23/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/11/2020

EXT5

SOU EXTENSION 5 FILED

08/27/2020

EEXT

SOU TEAS EXTENSION RECEIVED

08/27/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/27/2020

EX4G

SOU EXTENSION 4 GRANTED

02/25/2020

EXT4

SOU EXTENSION 4 FILED

02/25/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/25/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/05/2019

EX3G

SOU EXTENSION 3 GRANTED

09/03/2019

EXT3

SOU EXTENSION 3 FILED

09/03/2019

EEXT

SOU TEAS EXTENSION RECEIVED

09/03/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/03/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/03/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/06/2019

EX2G

SOU EXTENSION 2 GRANTED

03/04/2019

EXT2

SOU EXTENSION 2 FILED

03/04/2019

EEXT

SOU TEAS EXTENSION RECEIVED

03/04/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/07/2018

EX1G

SOU EXTENSION 1 GRANTED

09/05/2018

EXT1

SOU EXTENSION 1 FILED

09/05/2018

EEXT

SOU TEAS EXTENSION RECEIVED

09/05/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/13/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/16/2018

PUBO

PUBLISHED FOR OPPOSITION

01/16/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/27/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/07/2017

DOCK

ASSIGNED TO EXAMINER

12/07/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/13/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2017

NWAP

NEW APPLICATION ENTERED

09/09/2017

Continuous trademark protection

Get notified about every new filing that threatens INTELLISEQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.